Collectively, this novel cardiomyocyte interactome will allow a more thorough understanding of MEF2A function in gene networks in the heart and possibly lead to important biological insights regarding the role of MEF2A in the heart under pathologic conditions such as cardiac hypertrophy and heart failure. Here, MEF2A is linked to cardiac hypertrophy.